Sarah joined The Column Group in 2021. Previously she was the Vice President of Protein Sciences at Genetech where she oversaw the large molecule drug discovery efforts and mentored project teams on the identification and optimization of more than 35 clinical candidates. Earlier, as a member of the Genentech Small Molecule Leadership Team, she supported project teams in advancing more than 25 molecules to IND-enabling studies and had a leading role in a collaboration with AbbVie and the Walter and Eliza Hall Institute that resulted in the discovery of Venclexta. Sarah earned a B.A. in Chemistry from Swarthmore College and a Ph.D. in Biophysics from the University of California, San Francisco.